In another mouse model, a NOD2 mutation potentiated NF-κB activity and IL-1β processing, suggesting that NOD2 may act as a positive regulator of NF-κB activation and IL-1β secretion, thereby increasing the intestinal inflammation observed in Crohn’s disease patients (Maeda et al., 2005). This evidence concerns the gene IL1B and Crohn disease.